Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension

NCT01866111 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT01866111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01866111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Lead sponsor
SK Life Science, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
October 31, 2021
Enrollment
437 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

partial epilepsy